title: Safety of 18F-DOPA injection for PET of carcinoid tumor.
authors.forename: Valérie
authors.initials: V
authors.lastname: Nataf
authors.forename: Macha
authors.initials: M
authors.lastname: Balard
authors.forename: Virginie
authors.initials: V
authors.lastname: de Beco
authors.forename: Khaldoun
authors.initials: K
authors.lastname: Kerrou
authors.forename: Fabrice
authors.initials: F
authors.lastname: Gutman
authors.forename: Dany
authors.initials: D
authors.lastname: Grahek
authors.forename: Françoise
authors.initials: F
authors.lastname: Montravers
authors.forename: Jean-Noël
authors.initials: JN
authors.lastname: Talbot
mesh_terms: D002276:Carcinoid Tumor / Q000000981:diagnostic imaging* / Q000556:secondary; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005462:Fluorine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008303:Malignant Carcinoid Syndrome / Q000139:chemically induced*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine